BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 11820463)

  • 21. The potential role of amifostine in conjunction with cisplatin in the treatment of locally advanced carcinoma of the cervix.
    Wadler S; Goldberg G; Fields A; Anderson P; Beitler JJ; Sood B; Haynes H; Runowicz C
    Semin Oncol; 1996 Aug; 23(4 Suppl 8):64-8. PubMed ID: 8783670
    [TBL] [Abstract][Full Text] [Related]  

  • 22. First results of triple-modality treatment combining radiotherapy, chemotherapy, and hyperthermia for the treatment of patients with stage IIB, III, and IVA cervical carcinoma.
    Westermann AM; Jones EL; Schem BC; van der Steen-Banasik EM; Koper P; Mella O; Uitterhoeve AL; de Wit R; van der Velden J; Burger C; van der Wilt CL; Dahl O; Prosnitz LR; van der Zee J
    Cancer; 2005 Aug; 104(4):763-70. PubMed ID: 15968685
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improved survival after concurrent weekly cisplatin and radiotherapy for cervical carcinoma with assessment of acute and late side-effects.
    King M; McConkey C; Latief TN; Hartley A; Fernando I
    Clin Oncol (R Coll Radiol); 2006 Feb; 18(1):38-45. PubMed ID: 16477918
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A phase II trial of less than 7 weeks of concomitant cisplatin-paclitaxel chemoradiation in locally advanced cervical cancer.
    Martínez-Monge R; Gaztañaga M; Aramendía JM; Cambeiro M; Arbea L; Espinós J; Aristu JJ; Jurado M
    Int J Gynecol Cancer; 2010 Jan; 20(1):133-40. PubMed ID: 20130514
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
    Morris M; Eifel PJ; Lu J; Grigsby PW; Levenback C; Stevens RE; Rotman M; Gershenson DM; Mutch DG
    N Engl J Med; 1999 Apr; 340(15):1137-43. PubMed ID: 10202164
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pelvic radiation with concurrent chemotherapy compared with pelvi and para-aortic radiation for high-risk cervical cancer. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. Cisplatin, radiation, and adjuvant hysterectomy for bulky stage Ib cervical carcinoma].
    Nöel G; Mazeron JJ
    Cancer Radiother; 1999; 3(4):345-7. PubMed ID: 10515699
    [No Abstract]   [Full Text] [Related]  

  • 27. Concurrent mitomycin C, 5-fluorouracil, and radiotherapy in the treatment of locally advanced carcinoma of the cervix: a randomized trial.
    Lorvidhaya V; Chitapanarux I; Sangruchi S; Lertsanguansinchai P; Kongthanarat Y; Tangkaratt S; Visetsiri E
    Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1226-32. PubMed ID: 12654431
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of locally advanced cervical cancer.
    Rojas-Espaillat LA; Rose PG
    Curr Opin Oncol; 2005 Sep; 17(5):485-92. PubMed ID: 16093801
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Topotecan in cervical cancer.
    Ackermann S; Beckmann MW; Thiel F; Bogenrieder T
    Int J Gynecol Cancer; 2007; 17(6):1215-23. PubMed ID: 17997795
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term survival data of triple modality treatment of stage IIB-III-IVA cervical cancer with the combination of radiotherapy, chemotherapy and hyperthermia - an update.
    Westermann A; Mella O; Van Der Zee J; Jones EL; Van Der Steen-Banasik E; Koper P; Uitterhoeve AL; De Wit R; Van Der Velden J; Burger C; Schem BC; Van Der Wilt C; Dahl O; Prosnitz LR; Van Tinteren H
    Int J Hyperthermia; 2012; 28(6):549-53. PubMed ID: 22788973
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comments on "Chemoradiation for carcinoma of the cervix: advances and opportunities" by Patricia Eifel (Radiat. Res. 154, 229-236, 2000).
    van der Zee J; Burger CW; Koper PC
    Radiat Res; 2001 Aug; 156(2):221-2. PubMed ID: 11448246
    [No Abstract]   [Full Text] [Related]  

  • 32. Nomograms Predicting Progression-Free Survival, Overall Survival, and Pelvic Recurrence in Locally Advanced Cervical Cancer Developed From an Analysis of Identifiable Prognostic Factors in Patients From NRG Oncology/Gynecologic Oncology Group Randomized Trials of Chemoradiotherapy.
    Rose PG; Java J; Whitney CW; Stehman FB; Lanciano R; Thomas GM; DiSilvestro PA
    J Clin Oncol; 2015 Jul; 33(19):2136-42. PubMed ID: 25732170
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hyperfractionated radiation therapy plus chemotherapy in locally advanced cervical cancer: results of two phase I dose-escalation Gynecologic Oncology Group trials.
    Calkins AR; Harrison CR; Fowler WC; Gallion H; Mangan CE; Husseinzadeh N; Alvarez RD; Mychalczak B; Podczaski E
    Gynecol Oncol; 1999 Dec; 75(3):349-55. PubMed ID: 10600288
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term follow-up of a randomized trial comparing concurrent single agent cisplatin, cisplatin-based combination chemotherapy, or hydroxyurea during pelvic irradiation for locally advanced cervical cancer: a Gynecologic Oncology Group Study.
    Rose PG; Ali S; Watkins E; Thigpen JT; Deppe G; Clarke-Pearson DL; Insalaco S;
    J Clin Oncol; 2007 Jul; 25(19):2804-10. PubMed ID: 17502627
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neoadjuvant chemotherapy: an alternative option of treatment for locally advanced cervical cancer.
    Loizzi V; Cormio G; Vicino M; Selvaggi L
    Gynecol Obstet Invest; 2008; 65(2):96-103. PubMed ID: 17878736
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cervical cancer: radiotherapy and hyperthermia.
    van der Zee J; van Rhoon GC
    Int J Hyperthermia; 2006 May; 22(3):229-34. PubMed ID: 16754343
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Concurrent daily cisplatin and extended-field radiation therapy for carcinoma of the cervix.
    Uno T; Mitsuhashi A; Isobe K; Yamamoto S; Kawakami H; Ueno N; Usui H; Tate S; Kawata T; Ito H
    Int J Gynecol Cancer; 2008; 18(1):80-4. PubMed ID: 17466053
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost effectiveness of concurrent chemoradiation in comparison with radiation alone in locally advanced cervical cancer.
    Manusirivithaya S; Sripramote M; Tangjitgamol S; Sanjareonsuttikul N; Pisarnturakit P
    J Med Assoc Thai; 2005 Aug; 88(8):1035-44. PubMed ID: 16404829
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined-modality therapy of locally advanced cervical cancer.
    Rose PG
    J Clin Oncol; 2003 May; 21(10 Suppl):211s-217s. PubMed ID: 12743137
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neoadjuvant chemotherapy followed by radiotherapy and concurrent hyperthermia in patients with advanced-stage cervical cancer: a retrospective study.
    Heijkoop ST; Franckena M; Thomeer MG; Boere IA; Van Montfort C; Van Doorn HC
    Int J Hyperthermia; 2012; 28(6):554-61. PubMed ID: 22690721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.